Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Subst Abuse Treat ; 26(4): 285-94, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15182893

RESUMEN

Naltrexone may be more effective for treating opioid (heroin) dependence in Russia than in the U.S. because patients are mostly young and living with their parents, who can control medication compliance. In this pilot study we randomized 52 consenting patients who completed detoxification in St. Petersburg to a double blind, 6-month course of biweekly drug counseling and naltrexone, or counseling and placebo naltrexone. Significant differences in retention and relapse favoring naltrexone were seen beginning at 1 month and continuing throughout the study. At the end of 6 months, 12 of the 27 naltrexone patients (44.4%) remained in treatment and had not relapsed as compared to 4 of 25 placebo patients (16%; p<0.05). Since heroin dependence is the main way HIV is being spread in Russia, naltrexone is likely to improve treatment outcome and help reduce the spread of HIV if it can be made more widely available.


Asunto(s)
Dependencia de Heroína/rehabilitación , Naltrexona/uso terapéutico , Antagonistas de Narcóticos/uso terapéutico , Adulto , Análisis de Varianza , Terapia Combinada , Método Doble Ciego , Femenino , Humanos , Masculino , Proyectos Piloto , Psicoterapia , Federación de Rusia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...